Tofacitinib Citrate for the Treatment of Vitiligo: A Pathogenesis-Directed Therapy.
Tofacitinib Citrate for the Treatment of Vitiligo: A Pathogenesis-Directed Therapy.
B. Craiglow,B. King
2015 · DOI: 10.1001/jamadermatol.2015.1520
JAMA dermatology · 255 Citations
TLDR
A case of generalized vitiligo is reported for which treatment with tofacitinib citrate, an oral Janus kinase 1/3 inhibitor, resulted in significant repigmentation.